Healthcare
UPDATE 3-Actavis to buy Warner Chilcott in $5 billion stock deal
May 20 - Generic drugmaker Actavis Inc, itself the subject of takeover speculation, said on Monday it would buy specialty pharmaceutical company Warner Chilcott Plc for $5 billion in stock to expand its branded drug portfolio, lower taxes and increase profits.
AstraZeneca closes in on site for new home in Cambridge
* New research centre and corporate HQ to cost some $500 mln
UPDATE 1-U.S. Supreme Court agrees to hear Medtronic patent case
WASHINGTON, May 20 - The U.S. Supreme Court on Monday agreed to hear a patent dispute concerning Medtronic Inc over medical devices it manufactures that give the heart electrical jolts when it fails to pump blood properly.
UPDATE 2-FDA staff says Merck's sleep drug effective, questions dosage
* Designed to help patients fall asleep, stay asleep * Merck's shares fall 1.1 percent to $45.47 By Toni Clarke May 20 - Merck & Co's experimental insomnia drug suvorexant appears generally effective, according to reviewers at the U.S. Food and Drug Administration, but they questioned the company's proposed dosing levels. The reviewers posted their comments on the FDA's website on Monday, two days ahead of a meeting of outside medical experts which will advise the age
UK tries out new model for gene testing in cancer patients
LONDON, May 20 - Britain launched a research programme on Monday that should eventually allow all cancer patients to have access to the kind of genetic analysis that led Hollywood star Angelina Jolie to decide to undergo a double mastectomy.
| BSE OIL & GAS | -0.86% |
| BSE BANKEX | -0.92% |
| BSE-IT | +0.61% |
| BSE METALS | -0.01% |
| BSE REALTY | -0.70% |
| BSE AUTO | +0.82% |
| BSE POWER | -0.51% |
| BSE-FMCG | -0.18% |
| BSE-CG | -0.53% |
| BSE-HC | -1.79% |
Markets
- Sectors
- Asia
- U.S.
- Europe
Sector Summary
| Energy |  +0.41% |
| Basic Materials | +0.28% |
| Industrials | +0.63% |
| Cyclical Goods & Services | +0.50% |
| Non-Cyclical Goods & Services | +0.07% |
| Financials | +0.18% |
| Healthcare | +0.09% |
| Technology | +0.45% |
| Telecoms | +0.47% |
| Utilities | +0.68% |
| DOW | 15,345.75 |  -8.65 |
-0.06% |
| S&P 500 | 1,667.58 | +0.11 |
+0.01% |
| NASDAQ | 3,499.23 | +0.26 |
+0.01% |
| TR US Index | 151.34 | +0.04 |
+0.03% |
Essar Oil to sign $1 bln debt-for-fuel deal with China
MUMBAI/NEW DELHI - Essar Oil Ltd will sign a $1 billion loan deal with China on Tuesday that sources with knowledge of the matter said would be backed by supply of refined products to top state oil producer PetroChina.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
